Roy Dekel

1.6k total citations
34 papers, 1.2k citations indexed

About

Roy Dekel is a scholar working on Gastroenterology, Surgery and Molecular Biology. According to data from OpenAlex, Roy Dekel has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Gastroenterology, 17 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Roy Dekel's work include Gastroesophageal reflux and treatments (16 papers), Eosinophilic Esophagitis (9 papers) and Gastrointestinal motility and disorders (7 papers). Roy Dekel is often cited by papers focused on Gastroesophageal reflux and treatments (16 papers), Eosinophilic Esophagitis (9 papers) and Gastrointestinal motility and disorders (7 papers). Roy Dekel collaborates with scholars based in Israel, United States and India. Roy Dekel's co-authors include Ronnie Fass, Michael Shapiro, Justin L. Sewell, Ami D. Sperber, Ram Dickman, Zamir Halpern, Nitsan Maharshak, Keren Hod, Douglas A. Drossman and Colleen Green and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Oncogene.

In The Last Decade

Roy Dekel

34 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Roy Dekel 943 811 158 131 116 34 1.2k
Jean Paul Galmiche 1.1k 1.2× 866 1.1× 188 1.2× 73 0.6× 241 2.1× 45 1.4k
Jessica Valestin 767 0.8× 663 0.8× 56 0.4× 131 1.0× 149 1.3× 44 1.2k
Tanisa Patcharatrakul 754 0.8× 556 0.7× 50 0.3× 126 1.0× 159 1.4× 65 1.1k
Victor Chedid 722 0.8× 507 0.6× 76 0.5× 146 1.1× 340 2.9× 81 1.3k
Sang Pyo Lee 453 0.5× 482 0.6× 323 2.0× 109 0.8× 91 0.8× 56 976
Cesare Tosetti 1.4k 1.5× 1.1k 1.4× 142 0.9× 59 0.5× 380 3.3× 44 1.8k
Priya Vijayvargiya 1.0k 1.1× 675 0.8× 68 0.4× 199 1.5× 315 2.7× 51 1.5k
Chih‐Hsun Yi 755 0.8× 683 0.8× 126 0.8× 35 0.3× 101 0.9× 106 1.0k
H. Kaess 505 0.5× 445 0.5× 95 0.6× 76 0.6× 151 1.3× 85 873
Banny S. Wong 884 0.9× 749 0.9× 38 0.2× 227 1.7× 276 2.4× 26 1.4k

Countries citing papers authored by Roy Dekel

Since Specialization
Citations

This map shows the geographic impact of Roy Dekel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Dekel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Dekel more than expected).

Fields of papers citing papers by Roy Dekel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Dekel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Dekel. The network helps show where Roy Dekel may publish in the future.

Co-authorship network of co-authors of Roy Dekel

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Dekel. A scholar is included among the top collaborators of Roy Dekel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Dekel. Roy Dekel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vélez, Christopher, Trisha S. Pasricha, Dana Ben‐Ami Shor, et al.. (2023). Safety of Pneumatic Dilation in Older Adults with Achalasia: An International Multicenter Cross-Sectional Study. Journal of Clinical Medicine. 12(20). 6682–6682. 1 indexed citations
2.
Shapira, Shiran, E. Sh. Finkelshtein, Dina Kazanov, et al.. (2021). Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cells. Oncogene. 40(22). 3815–3825. 5 indexed citations
3.
Hod, Keren, Samuel Melamed, Roy Dekel, Nitsan Maharshak, & Ami D. Sperber. (2020). Burnout, but not job strain, is associated with irritable bowel syndrome in working adults. Journal of Psychosomatic Research. 134. 110121–110121. 13 indexed citations
4.
Dekel, Roy, et al.. (2019). Pancreatic cancer in bloom syndrome. SHILAP Revista de lepidopterología. 7. 2050313X19855587–2050313X19855587. 1 indexed citations
5.
Hod, Keren, Roy Dekel, Nathaniel A. Cohen, et al.. (2018). The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea‐predominant irritable bowel syndrome. Neurogastroenterology & Motility. 30(12). e13456–e13456. 44 indexed citations
6.
Dekel, Roy, Douglas A. Drossman, & Ami D. Sperber. (2013). The use of psychotropic drugs in irritable bowel syndrome. Expert Opinion on Investigational Drugs. 22(3). 329–339. 54 indexed citations
7.
Hod, Keren, Ram Dickman, Ami D. Sperber, et al.. (2011). Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome. Neurogastroenterology & Motility. 23(12). 1105–1110. 28 indexed citations
8.
Sperber, Ami D. & Roy Dekel. (2010). Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes. Journal of Neurogastroenterology and Motility. 16(2). 113–119. 61 indexed citations
9.
Dickman, Ram, et al.. (2007). Relationships Between Sleep Quality and pH Monitoring Findings in Persons with Gastroesophageal Reflux Disease. Journal of Clinical Sleep Medicine. 3(5). 505–513. 86 indexed citations
10.
Dvorak, Katerina, Ronnie Fass, Roy Dekel, et al.. (2006). Esophageal acid exposure at pH ≤ 2 is more common in Barrett’s esophagus patients and is associated with oxidative stress. Diseases of the Esophagus. 19(5). 366–372. 29 indexed citations
11.
Shapiro, Michael, et al.. (2006). Assessment of dietary nutrients that influence perception of intra‐oesophageal acid reflux events in patients with gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 25(1). 93–101. 43 indexed citations
12.
Kariv, Revital, et al.. (2006). Low-Dose Naltreoxone for the Treatment of Irritable Bowel Syndrome: A Pilot Study. Digestive Diseases and Sciences. 51(12). 2128–2133. 18 indexed citations
13.
Wong, W. M., J. Bautista, Roy Dekel, et al.. (2005). Feasibility and tolerability of transnasal/per‐oral placement of the wireless pH capsule vs. traditional 24‐h oesophageal pH monitoring – a randomized trial. Alimentary Pharmacology & Therapeutics. 21(2). 155–163. 83 indexed citations
14.
Fass, Ronnie, Michael Shapiro, Roy Dekel, & Justin L. Sewell. (2005). Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next?. Alimentary Pharmacology & Therapeutics. 22(2). 79–94. 320 indexed citations
15.
Dekel, Roy, et al.. (2004). The Role of Proton Pump Inhibitors in Gastro-oesophageal Reflux Disease. Drugs. 64(3). 277–295. 50 indexed citations
16.
Dekel, Roy & Ronnie Fass. (2003). Current perspectives on the diagnosis and treatment of functional esophageal disorders. Current Gastroenterology Reports. 5(4). 314–322. 3 indexed citations
17.
Dekel, Roy, Colleen Green, Richard E. Sampliner, et al.. (2003). Progression Or Regression of Barrett's Esophagus—Is It All in The Eye of The Beholder?. The American Journal of Gastroenterology. 98(12). 2612–2615. 29 indexed citations
18.
Dekel, Roy, et al.. (2003). Evaluation of Symptom Index in Identifying Gastroesophageal Reflux Disease-Related Noncardiac Chest Pain. Journal of Clinical Gastroenterology. 38(1). 24–29. 42 indexed citations
19.
Dekel, Roy, Thomas C. Pearson, Christopher S. Wendel, et al.. (2003). Assessment of oesophageal motor function in patients with dysphagia or chest pain — the Clinical Outcomes Research Initiative experience. Alimentary Pharmacology & Therapeutics. 18(11-12). 1083–1089. 91 indexed citations
20.
Dekel, Roy, et al.. (2003). Gliotoxin Ameliorates Development of Fibrosis and Cirrhosis in a Thioacetamide Rat Model. Digestive Diseases and Sciences. 48(8). 1642–1647. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Paul Galmiche Breakdown of academic impact, for papers by Jessica Valestin Breakdown of academic impact, for papers by Tanisa Patcharatrakul Breakdown of academic impact, for papers by Victor Chedid Breakdown of academic impact, for papers by Sang Pyo Lee Breakdown of academic impact, for papers by Cesare Tosetti Breakdown of academic impact, for papers by Priya Vijayvargiya Breakdown of academic impact, for papers by Chih‐Hsun Yi Breakdown of academic impact, for papers by H. Kaess Breakdown of academic impact, for papers by Banny S. Wong
Rankless by CCL
2026